New agreement expands access to state-of-the-art enteral delivery systems for hospital and home care patients
FLORHAM PARK, N.J., Feb. 22, 2013 /PRNewswire-USNewswire/ -- Nestle Health Science and Moog, Inc. announced today that effective immediately Nestle Health Science will become the exclusive distributor in the U.S. and Canada for Moog's EnteraLite ® Infinity ® Pump, including compatible administration sets and accessories. The EnteraLite ® Infinity ® Pump is regarded as one of the leading enteral (tube feeding) delivery systems in the North American market. The agreement between Nestle Health Science and Moog expands availability of a state-of-the-art enteral delivery system that can be used across the full continuum of care – for adult and pediatric patients in the hospital and at home. Working together, both companies are now well positioned to meet the needs of hospital, home care and other alternate site customers.
"We are very pleased to enter into this agreement with Moog so that we can offer an innovative product like the EnteraLite ® Infinity ® Pump through the strength of our established Sales Force in the U.S. and Canada," said David Yates, North American Region Head for the HealthCare Nutrition business within Nestle Health Science. "We see this agreement as an important part of our plan to fulfill the Nestle Health Science mission of Nourishing Personal Health by delivering innovative, patient centric nutritional solutions. With this agreement in place, Nestle Health Science offers the most comprehensive array of science-based nutritional formulas, enteral delivery systems and feeding tubes available in North America."
"The relationship between Nestle Health Science and Moog Medical Devices Group is an extremely important combination of the best that can be offered in the marketplace," said Martin Berardi, President, Moog Medical Devices Group. "Our relationship has developed into one where trust and cooperation is the main ingredient which will provide excellent outcomes today and also into the future."The terms of this agreement are not being disclosed.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts